Patents Assigned to American Cayanamid Company
  • Patent number: 5861301
    Abstract: A DNA sequence encoding a novel human growth factor receptor referred to as a type III receptor tyrosine kinase is described. The amino acid sequence of the receptor is also described. The receptor has a sequence which is similar to that of the kinase domains of known type III receptor tyrosine kinases, but which is unique in its kinase insert domain sequence. The receptor binds specifically to the vascular endothelial cell growth factor.
    Type: Grant
    Filed: November 23, 1992
    Date of Patent: January 19, 1999
    Assignee: American Cayanamid Company
    Inventors: Bruce Israel Terman, Miguel Eduardo Carrion